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LABORATORY AND FIELD INVESTIGATIONS WITH DIFENACOUM, A PROMISING NEW RODENTICIDE 
JOHN 0. BULL, Rodenticides Section, Plant Protection Division, Imperial Chemical Industries, Fernhurst, 
Haslemere, Surrey, England 
ABSTRACT: Difenacoum is a new rodenticide recently introduced on the British market; it 
is one of the most potent of a series of hydroxycoumarin-based anticoagulants. Difenacoum 
is effective against laboratory rats and mice resistant to conventional anticoagulants and 
has a marked selectivity in favour of non-target species. Vitamin K1 is an effective 
antidote and the hazard of secondary poisoning is minimal . laboratory and field trials 
confirm difenacoum's efficacy against wild resistant strains . Further work is in progress 
to evaluate the efficacy of difenacoum against other rodent pest s pec ies. 
INTRODUCTION 
The rapid introduction of warfarin into the United Kingdom during the early 1950's 
provided a much needed boost to the control of rats and mice and there was a short period 
during which rodent control was easier but at the same time, more effective. This utopian 
situation did not last long. Rats resis tant to both warfarin and diphacinone were soon 
confirmed in the Scottish lowlands (Boyle, 1960); anticoagulant resistance was also noted 
in mice (Dodsworth, 1961). Since then, the incidence of resistance has increased 
considerably, not only in the UK but in other countries, notably the United States (Brooks 
and Bowerman, 1975 ; Jackson.!:!_~·· 1975). 
In contrast with the comparative abundance of alternative pesti cides in agriculture, 
the re was no immediate replacement for warfarin and other anticoagulants. Since 1960, much 
effort has been expended in the UK by Government (Rowe et al., 1970) and private companies 
(Bull, 1967) to find alternative compounds. --
Routine screening of toxic materials re j ected by the pharmaceutical industry for 
h~man use proved time consuming and few compounds reached even the field trials stage (Rowe, 
1970) . Routine s ynthesis of new compounds in the pharmaceutical industry has thrown up 
very few promising new rodent ici des, notabl y norbormide, parachlorphenyl s ilatrane (Beiter 
et al., 1970) and a series of compounds from Rohm & Haas (Pea rdon, 1974). The two former 
compounds have not ful f illed their initial promi se (Rennison et al., 1968) and are now little 
used, while only one of the Rohm & Haas series (787) has reached"""i="egistration and marketing 
in the United States. 
A more fundamental approach was adopted by Hadler and Shadbolt (1975) who , after care-
fully e xam ining the current evidence on anticoagulant resistance and coagulation theory, 
proceeded to synthes ize a series of hydroxycoumarin-based anticoagulants, many of which 
showed exceptional potency to both normal and anticoagulant resistant rats . One of the 
most potent of the series is 3-(3-p-diphenyl-l,2,3,4-tetrahydronaphth-l-yl)-4-hydroxycoumarin, 
the proposed British Standard Common name being difenacoum. The present paper examines the 
properties and toxicity of difenacoum and reviews laboratory and field performance in the 
UK and other parts of the world. 
STRUCTURE OF OIFENACOUM 
The anticoagulant coumatetralyl has a higher activity than warfarin against resistant 
strains of Rattus norvegicus (Lund, 1972) possibly related to the size and complexity of the 
groups attached to the 4-hydroxycoumarin. The rationale of Hadler and Shadbolt (Joe. cit) 
in synthesizing compounds with sub s tituted phenyl groups attached by a three carbon chain to 
the 4-hydroxycoumarin moiety is illustrated in Figure I. Fuller details of the chemistry 
and structure/activity relati onships are given in the original paper. 
TOXIC ITV 
a) Acute 
Difenacoum is highly active against a nurrber of important rodent species (Table 1). 
In contrast with warfarin, difenacoum is more toxic to the Mus musculus than to Rattus 
no rvegi cus . Although the data are limited, the susceptibilities of Rattus rattus and its 
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Figure 1. Comparative structures of three 
rodent i ci des. 
Table 1. The acute oral toxicity of 
difenacoum to some rodents and domestic 
animals. 
Animal and Strain 
(Rattus norvegicus) 
Wistar male 
Wistar female 
Wild male 
Wi Id female 
Acute Oral 
LD50 (mg/kg) 
1. 8 
2. 5 
2.5 
3.5 
(Rattus rattus mindanensis) 
Wi 1 d male 7.0 
2.5 Wild female 
(Rattus argentiventer) 
(Mus musculus) LAC male 
Rabbit (Dutch male) 
Dog (Beagle) 
Cat 
Pig (large white) 
Guinea pig 
Chicken (Leghorn ma le) 
0.7 
0.8 
2. 0 
50 
100 
80-100 
50 
so 
sub-species are of the same order as that of R. norvegicus. This again contrasts with 
warfarin since R. rattus has required a concentration about five times more than that for 
!· norvegicus (Bentley and Larthe, 1959). 
For non-target species, difenacoum is much less toxic; in particu lar the pig is far 
less susceptible than to warfarin (Papworth, 1958) for which a dose of 1 mg/kg has been 
recorded as lethal. 
b) Chronic 
Groups of male Wistar rats and male LAC mice were given a graded series of doses of 
difenacoum on five consecutive days to establish its cumulative toxicity vis-a-vis warfarin. 
The chronic oral Lo50 was established as 5xO.15 mg/kg for rats and 5 x 0.07 mg/kg for mice . In each instance the cumulative dose was about half of the acute. Asimilar test on 
homozygous resistant (Welsh strain) R. norvegicus gave 5 x 0.54 mg/kg, from which a resist-
ance factor of about x 3 can be deduced in comparison with non-resistant animals. 
At first sight, the activity of difenacoum seems to differ from warfarin for which the 
ratio of acute to chronic dose is taken to be large, i . e. > 50 mg/kg: 5 x 0.5 mg/kg (Hayes 
and Gaines, 1950) . Reviewing other work on warfarin, Bentley and Larthe (1959) list acute 
oral LD50 values ranging from 1.3-323 mg/kg the most widely quoted being 60 mg/kg. Because 
of these disparities and to allow valid comparison of warfarin with difenacoum, new 
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determinations have been made. The oral LD50 of high purity warfarin in glycol solution 
to female rats was 8.5 mg/kg, 95% confidence limits 4-15 mg/kg (1'\. Hadler, personal 
communication). The Lo50 of an aqueous suspension of warfarin was 6 .9 mg/kg, 95% 
confidence limits 4.3-11 (R. Parkinson, personal communication) . 
These data on warfarin indicate that the ratio of chronic to acute is less than has 
been widely accepted and that the safety margin may be less than has been supposed. 
Further work is in progress to resolve the apparent discrepancy . 
c) Hazards to domestic animals 
High potency per se is sometimes taken out of context and without reference to the 
end-use concentration.~Data is therefore included on various rodenticide to compare their 
hazards to non-target species (Table 2). The calculations for warfarin are based on early 
published work and take no account of the data given in the previous paragraph . The margins 
of safety offered by difenacoum need no further comment. 
Table 2 . Amount of bait (grams) required to deliver 1 acute LD50 dose of various 
rodenticides to different species. 
Species & 
Body weight. ZN3 Py (kg) (2. 5% 
Rat 0. 25 I 0. 45 
Mouse 0.025 j -
Rabbit 1.0 ! -
' Pig 50 ' 40-80 
Dog 5 ' 4-8 
Cat 2 j1. 6-3. 2 
Chicken 1 0. 8-1. 2 
References 5. 7 
(1) Peardon, 1974. 
(4) Yendt, 1970 . 
(7) Garner , 1967. 
Rodenticidal baits 
1080 RH787 Vi t . D2 Warfarin Di fenacoum 
(0.25%) (2. 0%) (0. 1 %) (0 .025%) (0 . 005%) 
0.25 0. 15 14 58 9 
o. 17 0 . 12 0.75 37 0 .4 
i 3,200 40 - ~> 15.0 -
60-80 40,000 125 . 0 - 200-1 ,000 
0. 12-0 . 4 ~ 250 15 400-5,000 5,000 
0.24-0.4 <10 - I 8-320 4,000 
I 
4-12 36 - I > 4 ,000 1,000 
! 
6, 7 1 4, 8 2. 3 
(2) Hagan & Radomski, 1953. 
(5) Martin, 1974. 
(3) Papworth, 1958. 
(6) Spector, 1959. 
(8) Ward Blenkinsop, 1975 . 
TOXICITY OF IMPURITIES PRESENT IN DIFENACOUM 
Analysis shows two main impurities in difenacoum; 4-hydroxycoumarin and 2-p-diphenyl-
1,2-dihydronaphthalene. Oral dosing of these compounds in polyethylene glycol to mice gave 
acute oral LD5o 's of >200 mg/kg and 180 mg/kg respectively. The corresponding LD50 for 
difenacoum against mice is 0.8 mg/kg and since neither of the impurities is present at 
more than 2-3% in technical difenacoum they can be ignored as toxic components. 
ANTICOAGULANT ACTIVITY 
The structure, method of synthesis and mode of action of difenacoum are all character-
istic of a classical indirect anticoagulant . The activity of difenacoum was compared with 
that of some other commonly used anticoagulants against Wistar Rats (Fig. 2); the most active 
of the warfarin isomers (s-) was the least effective compound tested and difenacoum the 
most effective with the othe r three compounds being inte rmediate. For homozygous resistant 
(Welsh strain) rats , differences between compounds were enormous (Fig . 3). The resistance 
factors between the strains varied from x 2 for difenacoum to about x 227 for diphacinone 
(Hadler, 1975a) . 
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Figure 2 . The effect on the extension of male Wistar rats 
prothrombin times following three daily oral administ rat ions 
of various rodentic i des . 
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Figure 3. The effect on the e xtension of prothromb in ti mes 
of homozygous resistant (Welsh strain) male rats following 
three daily oral administrations of various rodenticides . 
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ANTIDOTE STUDIES 
Vitamins K3 and KJ were tested as possible antidotes to difenacoum. As expected, Vitamin K3 was almost inactive; Vitamin Kl was much more effective. A single dose of 2 
mg/kg difenacoum killed 8/10 male mi ce (Fig. 4) while only 2/10 died when protected by 
daily injections of 10 mg/kg Vitamin K1. More detailed examination of the optimum dose for 
rats (Hadler, in preparation) has shown that doses of 10 mg/kg Vitamin K1 wi II provide 
effective protection against difenacoum at all levels up to 50 mg/kg. This compares with 
work on warfarin for which 1 mg/kg Vitamin K1 will protect against any level (Lowenthal and 
Macfarlane, 1964 ; L<:Menthal and Birnbaum, 1969). The higher level of Vitamin K1 required for difenacoum may only reflect the higher potency of the rodenticide but the data also 
indicate the prolonged action of difenacoum and underline the need for careful monitoring 
of antidotal measures taken in instances of accidental poisoning. However the delay of up 
to three days before death occurs is more than adequate time for instigation of effective 
prophylactic measures. 
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Figure 4. The effect of Vitamin K1 in reversing the anticoagulant 
action of a single dose of difenacoum given to LAC mice. 
SECONDARY TOXICITY 
Anticoagulants in general have a good record regarding toxicity to predators feeding 
on poisoned rodents . The possible hazard of difenacoum was elevated by feeding poisoned 
mice to rats for either one or three days. 
Determination of rat prothrorrbin times 24 hours after completion of feeding sh<:Med 
slightly greater elevat i on with warfarin than with difenacoum for the one day feed (Table 3); 
the situation was reversed for the three day feed, probably the result of the more prolonged 
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action of difenacoum. However the results are sufficiently close to suggest that 
dlfenacoum is unl ikely to offer significantly greater hazard than warfarin to non-target 
species. 
Table 3. The effect on prothrorrbin times of rats fed with difenacoum poisoned mice. 
Toxlcant Rat Hean Prothrorrbin times (secs) 
fed to No. 
mice One day feed Three day feed 
0 .005% 1 19 212+ 
dlfenacoum 2 27 100 
3 19 212+ 
0.0025% I 36 53 
warfarin 2 21 63 
3 36 35 
LONG TERM FEEDING STUDIES 
Although all available evidence showed that difenacoum acted only as an indirect 
anticoagulant, laboratory rats and mice were fed continuously with low concentrations of 
dlfenacoum (0. I ppm and 0.5 ppm respectively) in their diet for 12 weeks to elucidate other 
possible effects. During this period 3. 13 mg/kg was consumed by rats and I .48 mg/kg by 
mice (about 2 LD5o's in each case). Four out of 12 male rat s died in weeks 10 and 11 and 
one female in week eleven; only 2/25 male mice died . Al I deaths were attributable to 
classical anticoagulant hemorrhaging; moreover, histological examinati on detected no 
abnormalities in the organs of animals of either species . 
BAIT FEEDING STUDIES 
Baits were fed to homozygous resistant R. norvegicus to compare the activity of 
difenacoum with other rodenticides. Coumatetralyl again shOt'Jed its superiority over other 
conventional anticoagulants but was much less effective than di fenacoum which gave signifi-
cant mortality even at 10 ppm (Table 4). 
Table 4. Ten day no choice bait trials in female homozygous resistant (Welsh strain) 
R. norvegicusl. 
Ki II 
Anticoagulant Concentration (ppm) 
250 200 100 50 20 10 
War far in 0/5 0/5 
Diphacinone 0/5 
Ch lorophaci none 1/5 
Coumatetralyl 2/5 1/5 
Di fenacoum 5/5 5/5 10/10 10/1 0 7/10 
1From Hadler (1975b) 
Hore detailed studies at the Toworth Laboratories of the Ministry of Agriculture, 
Fisheries and Food on 0.005% difenacoum bait were made with ~· norvegicus, ~: rattus and 
Hus musculus (Hadler, Redfern and Rowe, 1975). These tests confi rmed the effi cacy of 
difenacoum in two day no-choice feeding (Table 5). Non-resistant rats were all killed; 
9/10 and 5/10 respectively of the resistant strains succumbed. Mice were less susceptible 
with 9/10 non-res istant and 13/15 resistant mice being killed . In similar tests with 
warfarin, a kill of 21/23 was obtained with non-resistant rats (Bentley and La rthe, loc. 
cit.) whereas no resistant rats would die . 
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Table 5. Mortality and bait consumption of wild rodents given a sole diet of 0 .005% difenacoum in pinhead 
oatmeal/corn oil bait for 2 days!. 
Survived 
2 Lethal dose dose of Species Type Sex Mean Morta 1 i ty Mean daily of active active 
body bait intake ingredient ingredient Days to 
weight (g) (mg/kg) (mg/kg) death 
Prebait3 Poison Mean Range Mean Range Mean Range 
Rattus NR M 179 515 18. 2 14. 2 8 1-17 4. 4 4-6 
norvegi cus NR F 149 515 16 . 1 11. 9 8 5-10 6.0 4-10 
R M 211 515 17. 6 13. 3 7 5-10 4. 8 3-6 
R F 208 4/5 16. 3 12. 7 7 4-12 6 7, 3 6-8 
Mus NR M 13 4/5 2.4 2 . 4 18 13-22 20 6.0 5-7 
muscul us NR F 13 315 2. 1 2 . 6 20 17-22 21 18-24 7. 3 6-9 
R M 15 515 3. 1 2. 6 18 9-23 5. 4 2-7 
R F 15 4/5 2 . 3 2.6 19 12-22 5. 4 2-7 
R F 15 4/5 2 . 3 2 . 6 19 12-22 14 7,5 6-10 
Rattus NR M 124 515 8 . 2 8.6 7 6-8 6 . 6 4-8 
rattus NR F 99 5/5 8.2 8.0 8 5-11 5. 6 4-7 
R M 158 3/5 12 . l 10.6 7 4-10 8 7-8 9,3 9-10 
R F 122 2/5 9 . 5 9, 1 7 6-7 8 8-9 9,5 6-13 
l From Hadler, Redfern and Rowe ( 1975). 
2NR = non-resistant, R = resistant to warfarin . 
3Last day only. 
"' 
"" 
Table 6. Bait consumption and mortality in wild R. norvegicus, R. rattus and M. musculus given a choice 
between pla i n and poisoned baits I. 
Mean daily Sign i fi-
2 Mean bait intake ca nee (P) Species Type body Du rat ion Concen- (g) of Mortality 
weight of test trat ion Student's 
(g) (days) (%) Poison Plain It I 
Rattus NR 190 2 0.3 1.5 15 . 3 < 0 . 001 14/20 
norvegi cus NR 178 2 0 .03 6 . 0 10.1 < 0 . 01 18/20 
NR 176 4 0.01 5.6 10 . 0 < 0 . 01 29/30 
NR 185 4 0.005 6.7 9.0 < 0 .02 29/30 
R 224 2 0.3 4.6 12. l < 0 . 01 15/20 
R 289 2 0.03 7 . 2 10 . 6 0 . 1-0 . 05 13/20 
R 212 4 0.01 5.9 10 . 6 < 0 . 001 27/30 
R 246 4 0.005 6.3 9.8 < 0 . 001 28/29 
Mus NR 13 2 0.3 0 . 4 2. 2 < 0 . 001 7/10 
muscul us NR 13 2 0 .03 1.0 1. 7 < 0 .01 8/10 
NR 12 4 0.01 1. 4 1.6 0 . 2-0. l 19/20 
NR 14 4 0 . 005 1. 5 1. 3 0 . 5-0 . 4 18/20 
R 14 2 0.3 0.7 2.2 < 0 . 001 7/10 
R 14 2 0 . 03 1. 1 1.6 < 0 . 001 7/10 
R 17 4 0.01 1.6 1.8 < 0 . 02 8/10 
R 17 4 0 . 005 I. 6 I. 4 0.6-0 . 5 19/20 
Rattus NR 127 4 0.005 3.3 7, 9 < 0 .01 10/10 
ra ttus R 152 4 0 .01 4. 3 9 . 5 0 . 3-0 .2 3/5 
R 156 4 0.005 2 . 3 6.6 < 0 .Ol 4/10 
1 From Hadler , Redfern and R<Me (1975) 
2 R = resistant, NR =non-resistant to warfarin. 
Choice tests were carried out on the three species using different feeding periods 
with various concentrat ions (Table 6). High concentrations of difenacoum were clearly 
unacceptable to~· musculus and~· norvegicus; at 0 .005% there was still some discrimina-
tion by the latter against difenacoum but kills were excellent. A further test co111>aring 
the acceptance of 0.025% warfarin with 0 .005% difenacoum showed insignificant preference 
for di fenacoum. 
Further tests on house mice in large pens confirmed that longer feeding periods were 
required to get good control and that slightly higher concentrations might be required 
(Table 7). However the Carrbridge strain of mice used in this experiment is known to have 
exceptional resistance to anticoagulants; field strains are likel y to be more susceptible 
and more readily controlled by difenacoum than the results above would suggest. 
Table 7. Summary of tests on house mice in pens (after Rowe, 1975). 
% Di fenacoum 
0.005% 
0.010% 
Fl ELD TRIALS 
No . mice 
tested 
81 
67 
No . ki 1 led % kill 
89 
65 97 
Days to death 
3-23 
3-15 
Oifenacoum was tested on a nurrber of farms in Wales and in Kent, since the resistant 
rats in these two areas probably represented d i fferent genetic strains {Rennison and Hadler, 
1975). Three farms were treated first with 0 . 025% warfarln and, not unexpectedly, all 
treatments were unsuccessful; the farms were then treated with 0.005% difenacoum and the 
rat infestations were eradicated (Fig. 5) . Eleven further farms were treated with 0.005% 
difenacoum and six farms with 0.010% difenacoum. The results showed that difenacoum 
effectively controlled wa rfarin resistant rats in both areas ; no practical difference could 
be demonstrated between the two concentrations used and the lower concentration was there- 1 fore chosen for -field use. Since Autumn 1974, difenacoum (under the trade name of I 
11Ne0Sorexa11 , registered trade mark of Ward Blenkinsop & Co . Ltd.) bait has been commercially I 
available to professional pest control operators, local authorities and large agricultural 
users and has proved remarkably s uccessful. 
TESTS ON OTHER STRAINS ANO SPECIES .. 
Oifenacoum at 0.01 % has also been tested against American strains of anticoagulant 
resistant~· norvegicus (Table 8) as well as~· !.· mindanensis from the Philippines and 
R. exulans from Hawaii (Scott, OWRC, personal communication) . The results were promising 
and further work is planned to test difenacoum under field conditions. Preliminary tests 
by Brooks and Bowerman (personal communication) conducted on five res is tant Norway rats from 
Chicago gave 100% mortality with 0.005% difenacoum after a 6 day no-choice feeding test. 
One hundred percent mortality of eight resistant house mice (Mus musculus) was also obtained 
after a 21 day no-choice test with 0 .005% difenacoum. Jacksoill"personal communication) has 
also conducted pre! iminary laboratory trials with 0.005% difenacoum baits on 10 Chicago 
resistant rats with complete mortality after a 6 day, no-choice test. In view of these 
result s and preliminary genetic data obtained for American resistant rats by Brooks and 
Bowerman (Joe . cit), it is expected that difenacoum will perform well under American 
conditions . 
Danish resistant rats (Lund, 1975) all died when subjected to the standard 6 day 
feed ing regime (Table 9). 
Evaluations of difenacoum against Rattus tiomanicus, an important pest of oil palm, 
and Rattus ar entiventer a rice field rat have shown promising results (B . J. Wood, personal 
communication . Oifenacoum at 0 . 01% ki lied all R. tiomanicus whether they ate 20g bait/day 
or were restricted to 5g (Fig. 6). Even 0.001 % under the latter regime killed nearly 90% 
of rats . Comparative field trials in oil palm have confirmed the promise of laboratory tests 
(Table 10: B.J . Wood, personal communication). Difenacoum at 0.0055% gave equivalent results 
to warfarin at 0 . 05% but 0.0275% difenacoum was more effective in that half the previous 
nurrber of rounds and baits were needed to obtain control. Further work is planned to deter-
mine the optimum concentration for use against ~· argentiventer. 
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Figure 5. The regression of rat populations on three farms after 
treatment with 0 .025% warfarin (broken lines) and afterwards with 
0.005% difenacoum (sol id lines) . Taken from Rennison and Had ler, 
1975. 
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Tab le 8. Effects of feed ing 0.0 1% di fenacoum to vari ous stra ins and species of rat. 
Species & Strain 
Ratt us norvegicus 
(N. Ca ro l ina res i s t ant) 
Rattus norvegicus 
(Denve r ) 
Ratt us ratt us 
min danensis (wi 1 d) 
Ratt us exul ans 
(w i 1 d) 
Type of 
feed ing 
No choice 
Free choice 
Free choice 
Free choice 
Ki 11 
10/ 10 
19/ 20 
10/10 
10/10 
Tabl e 9 . Effec ts of feeding rodent i cides to Danish 
Rodent i ci de No. of 
& Cone Rats 
0. 01% 10 
di fenacoum 
Six day 0 . 025% 10 
t est on warfari n 
resis t ant 
Ratt us 1 0 .01% 6 
norvegi c us di fenacoum 
0.005% 16 
di fenacoum 
lAfter Lund (1 975) 82 
Time to 
death 
3-9 
4- 11 
5-14 
4-13 
anticoagulant 
No . 
ki 1 l ed 
10 
5 
6 
16 
Acceptance 
Rat i o 
0 . 50 
0 .57 
0 . 63 
resistant 
Av. days 
to death 
5.8 
. (3-8) 
6 .8 
(5-10) 
7.2 
(5 -12) 
5.9 
(3- 9) 
Mean wt. 
chemica l 
ea ten 
8 mg/kg 
7 mg/kg 
13 mg/kg 
13. 5mg/kg 
rats. 
Av. aroount 
o f bai t 
ea t en g/kg 
247 
(91 - 491) 
283 
( 181-423) 
275 
(145-471 ) 
241 
( 103-384) 
Table 10. Results of field trials with difenacoum-based wax cubes against Rattus tioman icus 
under oil palms. 
Treatments No. of Bun en Dead rats No. of rounds No. of 
rats Damage seen during required to baits 
trapped Index treatment reach < 20% used per 
1 take 1 palm 
Bl Al B A 
DI fenacoum 8.0 0 4. I 0 64 4.5 2.6 
0.0275% 
Di fenacoum 8.o 0 6. 4 0 46 8. 0 4.8 
0.0055% 
Warfarin 8.0 0 I. 7 0 56 8.5 5.0 
0.05% 
Warfarin 8.5 0 2.6 0 53 10.0 7. 7 
0.01% 
Con tro 1 8.5 6.0 5. 1 I. 2 10 .02 10.02 
1B - Before treatment, A - After treatment . 
2Trial closed because all treatments have achieved 20% 'take'. 
Arvicanthis ni loticus (Ni le , grass or harsh furred rat) is a serious agricultural 
pest in Africa and parts of the Arabian peninsula . From comparative laboratory tests (Gill 
and Redfern, Pans In press) it appears that there is a factor of about x 7 in toxicity of 
0.005% difenacoum over 0 .025% warfarin; 100% kill was achieved after 2-3 days no choice 
feeding compared with 5-6 days with warfarin. Overall, the susceptibility of Arvicanthis 
to difenacoum appears to fall between that of .. ~: norvegicus and~· rattus (Anon., 1970). 
Gill and Redfern conclude that all the rodenticides tested, in suitable bait formulations, 
would be effective as practical control agents but rightly stress the need for practical 
field evaluation before definite conclusions can be drawn. 
CONCLUSIONS 
Difenacoum is still in an early stage of development and much work remains to be done 
but the product appears to be one of the most exciting developments in rodent control for 
many years . It has all the benefits of the •classical' anticoagulants and a wide spectrum 
of action against rodents, with the additional advantages of being active against anti-
coagulant resistant rats and having a marked degree of selectivity towards non-target 
species. 
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